SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand
7 references·2 citing·34 second hop
Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand (2007)Evaluation of a multiplex human immunodef…Hepatitis B virus blood screening: unfinished agendas (2006)Hepatitis B virus blood scree…Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings (2005)Predonation screening of bloo…Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Multicenter performance evalu…Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Probability of Viremia with H…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The cost‐effectiveness of NAT…Infectious disease markers in blood donors in northern Thailand (1995)Infectious disease markers in…IMPACT OF MULTIPLEX PCR IN REDUCING THE RISK OF RESIDUAL TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY AND HEPATITIS B AND C VIRUSES IN BURKINA FASO (2018)IMPACT OF MULTIPLEX PCR IN RE…Seroprevalence of human immunodeficiency virus in north Indian blood donors using third and fourth generation Enzyme linked immunosorbent assay (2013)Seroprevalence of human immun…The Cambridge Ancient History (1971)The Risk of Transfusion-Transmitted Viral Infections (1996)International application of the Incidence Rate/Window Period model (2002)Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA (2006)HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas® TaqScreen MPX test in seroconverting donors (2007)Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Markers for Transfusion- Transmissible Infections in North Indian Voluntary and Replacement Blood Donors: Prevalence and Trends 1989-1996 (1997)Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first‐time blood donors in São Paulo, Brazil (2005)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening (1990)Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost? (1995)Altruism and payment in blood donation (1997)Trends in the profile of blood donors at a large blood center in the city of São Paulo, Brazil (2003)Recommendations for Reporting Cost-effectiveness Analyses (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Estimating the cost of blood: past, present, and future directions (2007)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Hepatitis B and the Case of the Missing Women (2005)The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia (2007)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence of serological markers for Hepatitis B and C Viruses, human immuno-deficiency virus and Treponema pallidum among blood donors in Ouagadougou, Burkina Faso (2022)Residual risk of hepatitis B virus transmission through blood donations in Burkina Faso screened with rapid diagnostic tests (2022)Seroprevalence of viral transfusion transmissible infections (HBsAg, anti-HCV, anti-HIV, Syphilis) and coinfection among healthy volunteer blood donors during 5-years in Luanda, Angola (2023)Characteristics of blood donors and donated blood in sub‐Saharan Francophone Africa (2009)Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique (2011)Prevention of transfusion-transmitted infections (2019)
this work references cited by second hop

References

  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
  • 2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
  • 2004Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States196 cited
  • 2005Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings141 cited
  • 2006Hepatitis B virus blood screening: unfinished agendas94 cited
  • 2005Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations56 cited
  • 1995Infectious disease markers in blood donors in northern Thailand41 cited

Cited by

  • 2018IMPACT OF MULTIPLEX PCR IN REDUCING THE RISK OF RESIDUAL TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY AND HEPATITIS B AND C VIRUSES IN BURKINA FASO17 cited
  • 2013Seroprevalence of human immunodeficiency virus in north Indian blood donors using third and fourth generation Enzyme linked immunosorbent assay10 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work